Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Azarnoff

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Archives of Dermatology|May 1, 1972
Half-life of methotrexate: new evidenceD H Huffman, S H Wan, D L Azarnoff, et al.
The Journal of Cell Biology|May 1, 1974
Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in responseJ K Reddy, D L Azarnoff, D J Svoboda, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1975
1-methyl-4piperidyl-bis (P-chlorophenoxy) acetate: a new hypolipidemic peroxisome proliferatorJ K Reddy, T P Krishnakantha, D L Azarnoff, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1977
Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferatorsJ K Reddy, D E Moody, D L Azarnoff, et al.
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1980
Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotypeD D Shen, J P Hosler, R L Schroder, et al.
Clinical Pharmacology and Therapeutics|October 1, 1978
Gynecomastia induced in normal males by spironolactoneD H Huffman, J P Kampmann, C E Hignite, et al.
Clinical Pharmacology and Therapeutics|April 1, 1978
Correlation between plasma diphenhydramine level and sedative and antihistamine effectsS G Carruthers, D W Shoeman, C E Hignite, et al.
Clinical Pharmacology and Therapeutics|September 1, 1972
Absorption and excretion of clindamycin-2-phosphate in children after intramuscular injectionR E Kauffman, D W Shoeman, Suk-Han-Wan, et al.
The Journal of International Medical Research|January 1, 1974
The effect of spironolactone on plasma levels and excretion of testosterone and oestrogens in the urine in males. (A preliminary report)P J Pentikäinen, L A Pentikäinen, D H Huffman, et al.
Journal of Chromatography|November 1, 1978
Quantitation of chlordiazepoxide and its metabolites in biological fluids by thin-layer chromatographyJ L Straughan, W F Cathcart-Rake, D W Shoeman, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Archives of Dermatology|May 1, 1972
Half-life of methotrexate: new evidenceD H Huffman, S H Wan, D L Azarnoff, et al.
The Journal of Cell Biology|May 1, 1974
Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in responseJ K Reddy, D L Azarnoff, D J Svoboda, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1975
1-methyl-4piperidyl-bis (P-chlorophenoxy) acetate: a new hypolipidemic peroxisome proliferatorJ K Reddy, T P Krishnakantha, D L Azarnoff, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1977
Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferatorsJ K Reddy, D E Moody, D L Azarnoff, et al.
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1980
Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotypeD D Shen, J P Hosler, R L Schroder, et al.
Clinical Pharmacology and Therapeutics|October 1, 1978
Gynecomastia induced in normal males by spironolactoneD H Huffman, J P Kampmann, C E Hignite, et al.
Clinical Pharmacology and Therapeutics|April 1, 1978
Correlation between plasma diphenhydramine level and sedative and antihistamine effectsS G Carruthers, D W Shoeman, C E Hignite, et al.
Clinical Pharmacology and Therapeutics|September 1, 1972
Absorption and excretion of clindamycin-2-phosphate in children after intramuscular injectionR E Kauffman, D W Shoeman, Suk-Han-Wan, et al.
The Journal of International Medical Research|January 1, 1974
The effect of spironolactone on plasma levels and excretion of testosterone and oestrogens in the urine in males. (A preliminary report)P J Pentikäinen, L A Pentikäinen, D H Huffman, et al.
Journal of Chromatography|November 1, 1978
Quantitation of chlordiazepoxide and its metabolites in biological fluids by thin-layer chromatographyJ L Straughan, W F Cathcart-Rake, D W Shoeman, et al.
Pageof 12